Actinobacteria and Myxobacteria : Important Resources for Novel Antibiotics
Bacterial infections cause millions of deaths globally, particularly in children and the elderly, and four of the 10 leading causes of death are infectious diseases in low- and middle-income countries. The continuous use of antibiotics has resulted in multi-resistant bacterial strains all over the w...
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2020 |
| Language: | English |
| Physical Description: | 1 electronic resource (270 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 02516nam-a2200649z--4500 | ||
|---|---|---|---|
| 001 | 993545572004498 | ||
| 005 | 20231214133408.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202105s2020 xx |||||o ||| 0|eng d | ||
| 035 | |a (CKB)5400000000043471 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/69411 | ||
| 035 | |a (EXLCZ)995400000000043471 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Wink, Joachim |4 edt | |
| 245 | 1 | 0 | |a Actinobacteria and Myxobacteria |b Important Resources for Novel Antibiotics |
| 246 | |a Actinobacteria and Myxobacteria | ||
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
| 300 | |a 1 electronic resource (270 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | |a Open access |f Unrestricted online access |2 star | ||
| 520 | |a Bacterial infections cause millions of deaths globally, particularly in children and the elderly, and four of the 10 leading causes of death are infectious diseases in low- and middle-income countries. The continuous use of antibiotics has resulted in multi-resistant bacterial strains all over the world, such as Community-associated Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β-lactamases (ESBLs), and, as expected, hospitals have become breeding grounds for human-associated microorganisms, especially in critical care units. | ||
| 546 | |a English | ||
| 650 | 7 | |a Research & information: general |2 bicssc | |
| 650 | 7 | |a Biology, life sciences |2 bicssc | |
| 653 | |a actinomycetes | ||
| 653 | |a antibiotic biosynthesis | ||
| 653 | |a silent biosynthetic pathways | ||
| 653 | |a γ-butyrolactones | ||
| 653 | |a HiTES | ||
| 653 | |a translation inhibitors | ||
| 653 | |a marine actinobacteria | ||
| 653 | |a Streptomyces sp. | ||
| 653 | |a enzyme inhibition | ||
| 653 | |a antimicrobial | ||
| 653 | |a antioxidant | ||
| 653 | |a cytotoxicity | ||
| 653 | |a GC-MS | ||
| 653 | |a pyrrolopyrazines | ||
| 653 | |a myxobacteria | ||
| 653 | |a antivirals | ||
| 653 | |a secondary metabolites | ||
| 653 | |a HIV | ||
| 653 | |a Ebola | ||
| 653 | |a hepatitis viruses | ||
| 653 | |a diversity | ||
| 653 | |a uncultured | ||
| 653 | |a new antibiotics | ||
| 653 | |a Streptomyces | ||
| 653 | |a polyketides | ||
| 653 | |a secondary metabolite | ||
| 653 | |a polyketide synthases (PKSs) | ||
| 776 | |z 3-03943-529-9 | ||
| 776 | |z 3-03943-530-2 | ||
| 700 | 1 | |a Wink, Joachim |4 oth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:52:49 Europe/Vienna |f system |c marc21 |a 2022-04-04 09:22:53 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337984120004498&Force_direct=true |Z 5337984120004498 |b Available |8 5337984120004498 | ||